Area under the curve (AUC)

Definition

Area under the curve (AUC) is a key pharmacokinetic parameter that quantifies the total systemic exposure to a compound. Specifically, AUC is the area under the plot of plasma concentration (y-axis) versus time (x-axis) following a dose. AUC has units of concentration × time (e.g., nanograms·hour/milliliter). AUC represents the total amount of time that the compound is present in the bloodstream at any given concentration; a larger AUC indicates longer exposure or higher concentrations, or both. AUC is related to the dose and the clearance of the drug by the formula: AUC = Dose / Clearance. A drug that is rapidly cleared from the body (high clearance) produces a smaller AUC after a given dose than a drug that is slowly cleared (low clearance). AUC is used to compare the systemic exposure to a compound after different routes of administration, after different dose levels, or in different populations. In regulatory submissions, AUC is measured in clinical trials to characterize the pharmacokinetics of new therapeutic peptides and to determine whether dose adjustments are necessary in special populations such as those with liver or kidney disease.

AUC is calculated mathematically by integrating the plasma concentration-time curve using the trapezoidal rule (treating the curve as a series of trapezoids and summing their areas) or using other integration methods. The calculation requires multiple blood samples collected at various times after drug administration, producing a detailed concentration-time profile. From the AUC and other pharmacokinetic parameters (such as Cmax and Tmax), researchers calculate additional parameters including the volume of distribution, clearance, and half-life.

For bioequivalence studies (comparing two formulations of the same drug), AUC and Cmax are the primary parameters measured to determine whether a generic formulation produces equivalent systemic exposure to a brand-name formulation. For dose proportionality studies, AUC is measured after multiple dose levels to determine whether systemic exposure increases proportionally with dose (linear pharmacokinetics) or disproportionately (nonlinear pharmacokinetics). Nonlinear pharmacokinetics suggests saturation of absorption, metabolism, or elimination, which has implications for dose scaling.